Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Latest filing published 08 Oct 2026 for Halozyme Therapeutics, INC..
Filing timeline
BuySaleBernadette Connaughton
Insider track record
Disclosed buys
0
Disclosed sells
11
Signal history
Bernadette Connaughton: trading record in brief
Bernadette Connaughton (senior executive) discloses dealings in 2 companies, chiefly Halozyme Therapeutics, Inc. and Syneos Health, Inc. Over a trading history stretching from 7 September 2018 to 10 August 2026, the count stands at 28 filings.
Every open-market trade on record is a sale: 11 sales worth €997k. Other entries cover 14 share grants. So far in 2026, the count stands at no purchases and 4 sales.
On 8 October 2026 came the latest disclosure, a share grant in Halozyme Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bernadette Connaughton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
3,796 shares0Common StockSEC:0001159036-26-000139:0
1,626 shares@ US$102.800.0013% mcap20.2% of flowCommon StockSEC:0001662521-26-000002:0
1,625 shares@ US$66.210.0009% mcap12.9% of flowCommon StockSEC:0001159036-26-000072:0
1,625 shares@ US$63.480.0009% mcap12.3% of flowCommon StockSEC:0001159036-26-000055:0
2,000 shares@ US$70.250.0012% mcap16.7% of flowCommon StockSEC:0001159036-26-000006:0
829 shares@ US$71.607.1% of flowCommon StockSEC:0001159036-25-000065:0
2,000 shares@ US$68.4816.5% of flowCommon StockSEC:0001159036-25-000052:0
500 shares@ US$75.703.2% of flowCommon StockSEC:0001662521-25-000005:1
1,500 shares@ US$75.08613.4% of flowCommon StockSEC:0001662521-25-000005:0
2,977 shares@ US$73.6218.9% of flowCommon StockSEC:0001415889-25-023470:1
923 shares@ US$74.115.9% of flowCommon StockSEC:0001415889-25-023470:2
100 shares@ US$71.710.9% of flowCommon StockSEC:0001415889-25-023470:0
4,165 shares0Common StockSEC:0001415889-25-011767:0
6,501 shares0Common StockSEC:0001415889-24-011679:0
4,863 shares0Class A Common StockSEC:0001209191-23-050772:1
9,915 shares@ US$43.00100.0% of flowClass A Common StockSEC:0001209191-23-050772:0
4,863 shares0Class A Common StockSEC:0001209191-23-032940:0
8,065 shares0Common StockSEC:0001415889-23-007688:0
5,998 shares0Common StockSEC:0001415889-22-011511:0
2,839 shares0Class A Common StockSEC:0001209191-22-032624:0
6,206 shares0Restricted Stock UnitsSEC:0001179110-22-002907:0
2,364 shares0Class A Common StockSEC:0001209191-21-032806:0
5,230 shares0Restricted Stock UnitsSEC:0001179110-21-004970:0
2,803 shares@ US$62.4324.5% of flowClass A Common StockSEC:0001610950-20-000102:0
8,829 shares0Common StockSEC:0001179110-20-005376:0
25 of 28 declarations
